127 related articles for article (PubMed ID: 15242638)
1. Neddylating the guardian; Mdm2 catalyzed conjugation of Nedd8 to p53.
Harper JW
Cell; 2004 Jul; 118(1):2-4. PubMed ID: 15242638
[TBL] [Abstract][Full Text] [Related]
2. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.
Xirodimas DP; Saville MK; Bourdon JC; Hay RT; Lane DP
Cell; 2004 Jul; 118(1):83-97. PubMed ID: 15242646
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p53 degradation by Mdm2 acetylation.
Wang X; Taplick J; Geva N; Oren M
FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
[TBL] [Abstract][Full Text] [Related]
4. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
Buschmann T; Lerner D; Lee CG; Ronai Z
J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
[TBL] [Abstract][Full Text] [Related]
5. Modification of MDMX by sumoylation.
Pan Y; Chen J
Biochem Biophys Res Commun; 2005 Jul; 332(3):702-9. PubMed ID: 15907800
[TBL] [Abstract][Full Text] [Related]
6. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
7. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.
Stommel JM; Wahl GM
EMBO J; 2004 Apr; 23(7):1547-56. PubMed ID: 15029243
[TBL] [Abstract][Full Text] [Related]
8. Mdm2-SUMO1: is bigger better?
Melchior F; Hengst L
Nat Cell Biol; 2000 Sep; 2(9):E161-3. PubMed ID: 10980713
[No Abstract] [Full Text] [Related]
9. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
10. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination.
Badciong JC; Haas AL
J Biol Chem; 2002 Dec; 277(51):49668-75. PubMed ID: 12393902
[TBL] [Abstract][Full Text] [Related]
11. Regulation of p53 by Mdm2: fate is in the numbers.
Shmueli A; Oren M
Mol Cell; 2004 Jan; 13(1):4-5. PubMed ID: 14731389
[TBL] [Abstract][Full Text] [Related]
12. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Grönroos E; Terentiev AA; Punga T; Ericsson J
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
[TBL] [Abstract][Full Text] [Related]
13. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.
Sionov RV; Coen S; Goldberg Z; Berger M; Bercovich B; Ben-Neriah Y; Ciechanover A; Haupt Y
Mol Cell Biol; 2001 Sep; 21(17):5869-78. PubMed ID: 11486026
[TBL] [Abstract][Full Text] [Related]
14. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
[TBL] [Abstract][Full Text] [Related]
15. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
16. Regulation of p53 and MDM2 activity by MTBP.
Brady M; Vlatkovic N; Boyd MT
Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response.
Lyakhovich A; Shekhar MP
Mol Cell Biol; 2003 Apr; 23(7):2463-75. PubMed ID: 12640129
[TBL] [Abstract][Full Text] [Related]
18. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination.
Yan C; Lu D; Hai T; Boyd DD
EMBO J; 2005 Jul; 24(13):2425-35. PubMed ID: 15933712
[TBL] [Abstract][Full Text] [Related]
19. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
Honda R; Tanaka H; Yasuda H
FEBS Lett; 1997 Dec; 420(1):25-7. PubMed ID: 9450543
[TBL] [Abstract][Full Text] [Related]
20. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]